fda semaglutide warning november 2025 From a new Perspective by Amanda Banks, MD: On February 5, 2026, Hims & Hers, an online health and wellness platform, announced its intention to sell compounded oral semaglutide, a glucagon-like peptide-1 ( FDA warns Ozempic and Wegovy

The future of weight and longevity care wont belong to whoever prescribes the most Ozempic

Despite decades of public health messaging urging Americans to eat fewer calories , major trials have failed to demonstrate that calorie restriction meaningfully reduces cardiovascular disease, cancer, or mortality

While this keeps you feeling full, it poses a severe risk when you go under general anesthesia

However, there may be a link to gallbladder-related events

Shown to tighten skin, rather than leaving skin loose around the treated area

NAD+ is ideal for individuals over 40, those experiencing chronic fatigue, athletes seeking improved recovery, and people with cognitive decline